Skip to main content
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
16.52
+0.22 (1.35%)
At close: Aug 30, 2024, 4:00 PM
16.48
-0.04 (-0.23%)
After-hours: Aug 30, 2024, 6:21 PM EDT

Phathom Pharmaceuticals Revenue

Phathom Pharmaceuticals had revenue of $7.32M in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to $9.92M. In the year 2023, Phathom Pharmaceuticals had annual revenue of $682.00K.

Revenue (ttm)
$9.92M
Revenue Growth
n/a
P/S Ratio
96.27
Revenue / Employee
$21,942
Employees
452
Market Cap
1.11B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023682.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Aveanna Healthcare Holdings 1.95B
Artivion 376.97M
Silk Road Medical 191.43M
Calliditas Therapeutics AB (publ) 151.09M
Xencor 133.62M
Vir Biotechnology 78.88M
Immatics 75.94M
Perspective Therapeutics 1.46M
Revenue Rankings

PHAT News

More News